Literature DB >> 33520850

Glucose, lipid and oxidative stress lowering activity of the aqueous extract from leafy stems of Cissus polyantha Gilg & Brandt in dexamethasone-induced hyperglycemia in rats.

Abba Talba Mahamad1, David Miaffo2, Sylviane Laure Poualeu Kamani3, Oumar Mahamat4, Albert Kamanyi3, Sylvie Léa Wansi Ngnokam3.   

Abstract

BACKGROUND: Diabetes mellitus is a metabolic disorder characterised by chronic hyperglycemia. The present research work aimed to evaluate the hypoglycaemic, hypolipidemic and antioxidant effects of leafy stems of Cissus polyantha Gilg & Brandt in insulin resistant rats.
METHODS: The oral glucose tolerance test (OGTT) was performed in normal rats. Hyperglycemia was induced for 8 days by a daily subcutaneous injection of dexamethasone (1 mg/kg) one hour after pretreatment of animals with metformin (40 mg/kg) and C. polyantha extract (111, 222 and 444 mg/kg). Body weight, blood glucose, insulin level, lipid profile, insulin biomarkers, cardiovascular indices and oxidative stress biomarkers were evaluated.
RESULTS: For OGTT, the extract (444 mg/kg) produced a significant drop in blood sugar at the 60th (p < 0.01), 90th (p < 0.01) and 120th min (p < 0.05). Morever, the extract at doses of 222 and 111 mg/kg significantly reduced blood sugar at the 60th (p < 0.01) and 90th min (p < 0.05) respectively. Otherwise, C. polyantha (444 and 222 mg/kg) significantly (p < 0.001) increased body weight and decreased blood sugar on the 4th and 8th days of treatment in insulin resistant rats. The extract also significantly decreased (p < 0.001) serum insulin level, hyperlipidemia, insulin resistance index and cardiovascular indices, and increased gluthathione level, and superoxide dismutase and catalase activity.
CONCLUSION: The aqueous extract of Cissus polyantha leafy stems (AECPLS) possess hypoglycemic, hypolipidemic and antioxidant activities that could justify its use in traditional medicine for the prevention and treatment of diabetes mellitus and its complications. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Antioxidant; Cissus polyantha; Hypoglycemia; Hypolipidemia; Insulin resistance

Year:  2020        PMID: 33520850      PMCID: PMC7843746          DOI: 10.1007/s40200-020-00687-x

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  48 in total

Review 1.  Dissociated glucocorticoid receptor ligands.

Authors:  Heike Schäcke; Hartmut Rehwinkel
Journal:  Curr Opin Investig Drugs       Date:  2004-05

Review 2.  Antioxidant enzymes and human diseases.

Authors:  J M Matés; C Pérez-Gómez; I Núñez de Castro
Journal:  Clin Biochem       Date:  1999-11       Impact factor: 3.281

Review 3.  Oral antihyperglycemic therapy for type 2 diabetes mellitus.

Authors:  Alice Y Y Cheng; I George Fantus
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

Review 4.  Systematic review of herbs and dietary supplements for glycemic control in diabetes.

Authors:  Gloria Y Yeh; David M Eisenberg; Ted J Kaptchuk; Russell S Phillips
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

Review 5.  Oxidative stress in insulin-resistant conditions: cardiovascular implications.

Authors:  Craig S Stump; Suzanne E Clark; James R Sowers
Journal:  Treat Endocrinol       Date:  2005

Review 6.  Plant polyphenol antioxidants and oxidative stress.

Authors:  I Urquiaga; F Leighton
Journal:  Biol Res       Date:  2000       Impact factor: 5.612

Review 7.  Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.

Authors:  E Ferrannini
Journal:  Endocr Rev       Date:  1998-08       Impact factor: 19.871

8.  Membrane effects of vitamin E deficiency: bioenergetic and surface charge density studies of skeletal muscle and liver mitochondria.

Authors:  A T Quintanilha; L Packer; J M Davies; T L Racanelli; K J Davies
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

9.  Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial.

Authors:  Jeff Geohas; Anne Daly; Vijaya Juturu; Manley Finch; James R Komorowski
Journal:  Am J Med Sci       Date:  2007-03       Impact factor: 2.378

10.  Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome.

Authors:  E Ferrannini; S M Haffner; B D Mitchell; M P Stern
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.